首页> 美国卫生研究院文献>Therapeutic Advances in Neurological Disorders >Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis
【2h】

Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis

机译:重症肌无力控制良好的患者可以省略静脉免疫球蛋白预防胸腺切除术后的肌无力危象

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Myasthenic crisis (MC) is a potentially life-threatening complication of myasthenia gravis. Its precipitating factors include surgical procedures, particularly thymectomy. The role of preoperative intravenous immunoglobulin (IVIg) in preventing MC in patients scheduled for thymectomy and other surgery with general anaesthesia is unknown. Our objective was to test the hypothesis that preoperative IVIg is effective in preventing myasthenic crisis in patients with myasthenia gravis scheduled for surgery under general anaesthesia, including thymectomy.
机译:背景:重症肌无力危机(MC)是重症肌无力的潜在威胁生命的并发症。其诱发因素包括外科手术,特别是胸腺切除术。术前静脉免疫球蛋白(IVIg)在计划进行胸腺切除术和其他全身麻醉手术的患者中预防MC的作用尚不清楚。我们的目的是检验以下假说:术前IVIg可有效预防计划在全身麻醉(包括胸腺切除术)下进行手术的重症肌无力患者的肌无力危象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号